Cargando…
Single-Dose Lentiviral Mediated Gene Therapy Recovers CFTR Function in Cystic Fibrosis Knockout Rats
Cystic fibrosis (CF) is a genetic disease caused by mutations in the CF transmembrane conductance regulator (CFTR) gene, resulting in defective ion transport in the airways. Addition of a functioning CFTR gene into affected airway cells has the potential to be an effective treatment for lung disease...
Autores principales: | Reyne, Nicole, Cmielewski, Patricia, McCarron, Alexandra, Delhove, Juliette, Parsons, David, Donnelley, Martin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8167067/ https://www.ncbi.nlm.nih.gov/pubmed/34084147 http://dx.doi.org/10.3389/fphar.2021.682299 |
Ejemplares similares
-
Assessment of Lentiviral Vector Mediated CFTR Correction in Mice Using an Improved Rapid in vivo Nasal Potential Difference Measurement Protocol
por: Cmielewski, P., et al.
Publicado: (2021) -
To bead or not to bead: A review of Pseudomonas aeruginosa lung infection models for cystic fibrosis
por: Reyne, Nicole, et al.
Publicado: (2023) -
Breaching the Delivery Barrier: Chemical and Physical Airway Epithelium Disruption Strategies for Enhancing Lentiviral-Mediated Gene Therapy
por: McCarron, Alexandra, et al.
Publicado: (2021) -
Repeat or single-dose lentiviral vector administration to mouse lungs? It’s all about the timing
por: Donnelley, Martin, et al.
Publicado: (2023) -
Airway disease phenotypes in animal models of cystic fibrosis
por: McCarron, Alexandra, et al.
Publicado: (2018)